Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Allergists (New York)(?)

Council Members in this Study Group: 33

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Mitchell Boxer, MD
Assistant Clinical Professor
Albert Einstein College of Medicine

Mitchell Boxer, MD, is Director of the Adult Allergy Section at Long Island Jewish Medical Center and Assistant Clinical Professor at Albert Einstein Medical College. Dr. Boxer completed his fellowship at Northwestern University Medical College and has expertise in a wide range of allergic and immunologic...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Another nasal corticosteroid | 08-30-2007
Author: Mitchell Boxer, MD, Assistant Clinical Professor, Albert Einstein College of Medicine

A new nasal corticosteroid being released by another pharmaceutical company

Xyzal approval | 08-30-2007
Author: Mitchell Boxer, MD, Assistant Clinical Professor, Albert Einstein College of Medicine

Zyrtec will soon be available over the counter and this new product will attempt to keep the antihistamine market share for Sanofi-Aventis - although Zyrtec is presently manufactured by Pfizer.  The antihistamine market is quite large and the OTC versus prescription situation is making this problematic...

intranasal antibiotics for chronic sinusitis | 04-23-2007
Author: Mitchell Boxer, MD, Assistant Clinical Professor, Albert Einstein College of Medicine

I have not found nebulized antibiotic therapy to be of great success in patients with chronic sinusitis.  There are already a few pharmacies that have formulated an array of nebulized antibiotics and I have tried them in a few patients with no success.   

Xolair apprehension | 02-27-2007
Author: Mitchell Boxer, MD, Assistant Clinical Professor, Albert Einstein College of Medicine

There is a concern about anaphylaxis secondary to Xolair administration and this may result in longer waiting times after the administration of the drug.

Evaluation of Change therapy | 02-13-2007
Author: Mitchell Boxer, MD, Assistant Clinical Professor, Albert Einstein College of Medicine

HAE is a rare but potentially life threatening immunologic disease.  If c1 esterase inhibitor is found to be effective in preventing exacerbations of HAE than this novel treatment will have a great impact on the lives of those affected and will undoubtedly replace the present treatments such as...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Non-Academic Community Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Consultancy, Healthcare-Focused
  • Facility, Non-Academic/Community Hospital
  • Government/Military Hospital or Clinic
  • Healthcare Management
  • Integrated Healthcare Delivery Network (IDN)

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Physician - Division Head
  • Owner
  • Director
  • Physician - Department Chair
  • Medical Director
  • Physician - Resident
  • President

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-04T13:45:22.160